Literature DB >> 26589898

Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Enyinnaya Ofo1, Selvam Thavaraj2, Daron Cope3, James Barr3, Karan Kapoor3, Jean-Pierre Jeannon3, Richard Oakley3, Claire Lock2, Edward Odell2, Ricard Simo3.   

Abstract

Differentiated thyroid cancer (DTC) accounts for over 90 % of thyroid malignancies, and is frequently associated with central neck compartment nodal metastasis that requires a therapeutic central compartment neck dissection (CCND) for clinically evident nodes. Current knowledge on the expected lymph node yield from a CCND is limited, compared with data on the lateral neck. The aim of our study was to accurately quantify nodal yield from the cadaveric central neck compartment. Twenty-eight cadaveric necks were dissected and the central neck compartment was subdivided into four regions: pre-laryngeal (delphian), pre-tracheal, right and left para-tracheal regions. Each cadaver had a thyroid gland, which was also removed, and the CCND tissue in each compartment was processed and examined by a consultant histopathologist. Only lymphoid tissue with a defined microscopic fibrous capsule and subcapsular sinus was included in the node count. The median total lymph node count per cadaver was four (range 1-16), with a median of one node detectable in each para-tracheal region (range 0-7) and the pre-tracheal region (range 0-8). The median pre-laryngeal node count was 0 (range 0- 2). The average lymph node size across all compartments was 2.9 mm. This is the first European study to assess cadaveric central neck lymph nodes and establish baseline counts for nodal yield. If a prophylactic or therapeutic CCND is required during thyroid surgery, those involved in DTC management must recognise that there is a wide range, and low median yield of central neck compartment lymph nodes.

Entities:  

Keywords:  Cadaver; Central neck dissection; Lymph node yield; Pathology; Thyroid cancer; Thyroidectomy

Mesh:

Year:  2015        PMID: 26589898     DOI: 10.1007/s00405-015-3827-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  38 in total

1.  Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.

Authors:  David T Hughes; Matthew L White; Barbra S Miller; Paul G Gauger; Richard E Burney; Gerard M Doherty
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

2.  Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.

Authors:  Amanda M Laird; Paul G Gauger; Barbra S Miller; Gerard M Doherty
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 3.  Nodal yield in selective neck dissection.

Authors:  Rikke Norling; Marianne H Therkildsen; Patrick J Bradley; Michael B Nielsen; Christian von Buchwald
Journal:  Acta Otolaryngol       Date:  2013-09       Impact factor: 1.494

4.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 5.  Does senescence affect lymph node number and morphology? A systematic review.

Authors:  Omid Ahmadi; John L McCall; Mark D Stringer
Journal:  ANZ J Surg       Date:  2013-01-25       Impact factor: 1.872

6.  Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.

Authors:  Tarek Zetoune; Xavier Keutgen; Daniel Buitrago; Hasan Aldailami; Huibo Shao; Madhu Mazumdar; Thomas J Fahey; Rasa Zarnegar
Journal:  Ann Surg Oncol       Date:  2010-07-02       Impact factor: 5.344

7.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.

Authors:  Mark Sywak; Lachlan Cornford; Paul Roach; Peter Stalberg; Stan Sidhu; Leigh Delbridge
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

8.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

9.  Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.

Authors:  Sally E Carty; David S Cooper; Gerard M Doherty; Quan-Yang Duh; Richard T Kloos; Susan J Mandel; Gregory W Randolph; Brendan C Stack; David L Steward; David J Terris; Geoffrey B Thompson; Ralph P Tufano; R Michael Tuttle; Robert Udelsman
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

10.  Changing trends in well differentiated thyroid carcinoma over eight decades.

Authors:  Iain J Nixon; Ian Ganly; Snehal G Patel; Frank L Palmer; Monica M Whitcher; Rony Ghossein; R Michael Tuttle; Ashok R Shaha; Jatin P Shah
Journal:  Int J Surg       Date:  2012-11-02       Impact factor: 6.071

View more
  2 in total

1.  National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.

Authors:  Eun Hae Estelle Chang; Waseem Lutfi; Joseph Feinglass; Alexandra Eudokia Reiher; Tricia Moo-Young; Mihir Kiran Bhayani
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

Review 2.  Total Thyroidectomy with Central Node Dissection is a Valuable Option in Papillary Thyroid Cancer Treatment.

Authors:  Marija Pastorčić Grgić; Boris Stubljar; Pavao Perše; Mirta Zekan Vučetić; Sanda Šitić
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.